Lalezari Jacob P 4
4 · CytoDyn Inc. · Filed Mar 8, 2024
Insider Transaction Report
Form 4
CytoDyn Inc.CYDY
Lalezari Jacob P
Interim CEO
Transactions
- Award
Non-qualified stock option (right to buy)
2024-03-07+3,000,000→ 3,000,000 totalExercise: $0.21Exp: 2034-03-07→ Common Stock (3,000,000 underlying)
Footnotes (1)
- [F1]The stock option will vest and become exercisable in 48 monthly installments beginning on April 7, 2024 and ending on March 7, 2028, subject to Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date.